✦ LIBER ✦

Treatment disparities in Parkinson's disease

✍ Scribed by Nabila Dahodwala; Ming Xie; Elizabeth Noll; Andrew Siderowf; David S. Mandell

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 64 KB
Volume: 66
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21774

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Parkinson's disease: Disagr

Treatment of Parkinson's disease: Disagreements

✍ Michael Schulzer 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

The initial treatment of Parkinson's dis

The initial treatment of Parkinson's disease

✍ Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Treatment of Parkinson's disease with Ci

Treatment of Parkinson's disease with Ciladopa

✍ Michael J. Aminoff; Douglas S. Goodin; Barbara Habermann-Little; John R. Cutler 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Viral vectors in the treatment of Parkin

Viral vectors in the treatment of Parkinson's disease

✍ David S. Latchman; Robert S. Coffin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro

Parkinson's disease

✍ Edward P. Richardson Jr 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Deprenyl in Parkinson's disease

✍ Amos D Korczyn; Puiu Nisipeanu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views